COVID-19 Updates: At-a-glance resource, Caution on Hydroxychloroquine or Chloroquine use, Remote digital pathology devices
FDA COVID-19 RESPONSE: At-a-Glance Summary
Major focus areas
- Testing, therapeutics, and devices such as ventilators and personal protective equipment
- Vaccine development
- Food supply
- Action on fraudulent products
Cautions against use of hydroxychloroquine or chloroquine for COVID-19 due to risk of heart rhythm problems
- Reports of serious and potentially life-threatening heart rhythm problems
- May be mitigated when health care professionals closely screen and supervise COVID-19 patients in a hospital setting or a clinical trial
Remote Digital Pathology Devices During COVID-19 Emergency
Guidance to help expand the availability of digital pathology devices for remote reviewing and reporting of scanned digital images of pathology slides during this pandemic
- Automated Digital Image Manual Interpretation Microscope
- Whole Slide Imaging System
- Digital Pathology Image Viewing and Management Software
- Digital Pathology Display
Expanded, off-label use for the duration of the COVID-19 public health emergency
- Facilitate remote reviewing and reporting of pathology slides
- Help facilitate continuity of patient care
- Reduce healthcare personnel contact and risk of exposure
Image credit: FDA